Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-06-30 Purchase | 2021-12-02 5:16 pm | CTI BIOPHARMA CORP | CTIC | Craig Adam R CEO | 3,500 | $1.525 | $5,337 | 13,500 (Direct) | View |
| 2021-04-01 Purchase | 2021-04-05 8:15 pm | CTI BIOPHARMA CORP | CTIC | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N 10% Owner | 2,000,000 | $2.5 | $5,000,000 | 2,153,822 (Indirect Direct) | View |
| 2021-01-07 Sale | 2021-01-11 4:46 pm | CTI BIOPHARMA CORP | CTIC | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC 10% Owner | 2,000,000 | $3.5 | $7,000,000 | 7,520,600 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-03-09 Option Award | 2022-03-11 9:03 pm | N/A 2032-03-09 | CTI BIOPHARMA CORP | CTIC | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N 10% Owner | 80,000 | $0 | 9,379,051 (Indirect) | View |
| 2022-03-09 Option Award | 2022-03-11 7:48 pm | N/A 2032-03-09 | CTI BIOPHARMA CORP | CTIC | Tuckson Reed Vaughn Director | 80,000 | $0 | 80,000 (Direct) | View |
| 2022-03-09 Option Award | 2022-03-11 7:46 pm | N/A 2032-03-09 | CTI BIOPHARMA CORP | CTIC | PERRY MATTHEW D Director | 80,000 | $0 | 80,000 (Direct) | View |
| 2022-03-09 Option Award | 2022-03-11 7:46 pm | N/A 2032-03-09 | CTI BIOPHARMA CORP | CTIC | Parks Diane L. Director | 80,000 | $0 | 80,000 (Direct) | View |
| 2022-03-09 Option Award | 2022-03-11 7:45 pm | N/A 2032-03-09 | CTI BIOPHARMA CORP | CTIC | Parkinson David Ross Director | 80,000 | $0 | 80,000 (Direct) | View |
| 2022-03-09 Option Award | 2022-03-11 7:43 pm | N/A 2032-03-09 | CTI BIOPHARMA CORP | CTIC | Metzger Michael A Director | 80,000 | $0 | 80,000 (Direct) | View |
| 2022-03-09 Option Award | 2022-03-11 7:42 pm | N/A 2032-03-09 | CTI BIOPHARMA CORP | CTIC | Fischer Laurent Director | 80,000 | $0 | 80,000 (Direct) | View |
| 2021-06-30 Option Award | 2022-03-11 7:41 pm | N/A 2032-03-09 | CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID CFO | 280,000 | $0 | 287,397 (Direct) | View |
| 2021-06-30 Option Award | 2022-03-11 7:41 pm | N/A N/A | CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID CFO | 1,782 | $2.125 | 287,397 (Direct) | View |
| 2021-06-30 Option Award | 2022-03-11 7:41 pm | N/A N/A | CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID CFO | 1,817 | $2.108 | 287,397 (Direct) | View |
| 2021-06-30 Option Award | 2022-03-11 7:40 pm | N/A 2032-03-09 | CTI BIOPHARMA CORP | CTIC | SEELEY BRUCE J. EVP Chief Operating Officer | 280,000 | $0 | 323,905 (Direct) | View |
| 2021-06-30 Option Award | 2022-03-11 7:40 pm | N/A N/A | CTI BIOPHARMA CORP | CTIC | SEELEY BRUCE J. EVP Chief Operating Officer | 3,164 | $2.125 | 323,905 (Direct) | View |
| 2021-06-30 Option Award | 2022-03-11 7:40 pm | N/A N/A | CTI BIOPHARMA CORP | CTIC | SEELEY BRUCE J. EVP Chief Operating Officer | 3,241 | $2.108 | 323,905 (Direct) | View |
| 2021-12-31 Option Award | 2022-03-11 7:39 pm | N/A 2032-03-09 | CTI BIOPHARMA CORP | CTIC | Craig Adam R CEO | 1,115,000 | $0 | 1,131,678 (Direct) | View |
| 2021-12-31 Option Award | 2022-03-11 7:39 pm | N/A N/A | CTI BIOPHARMA CORP | CTIC | Craig Adam R CEO | 3,178 | $2.108 | 1,131,678 (Direct) | View |
| 2022-02-28 Ownership | 2022-03-11 7:37 pm | N/A N/A | CTI BIOPHARMA CORP | CTIC | Fong James K See Remarks | 0 | $0 | 933,395 (Direct) | View |
| 2021-06-30 Option Award | 2021-12-02 5:16 pm | N/A N/A | CTI BIOPHARMA CORP | CTIC | Craig Adam R CEO | 5,000 | $2.125 | 13,500 (Direct) | View |
| 2021-08-24 Ownership | 2021-09-03 4:00 pm | N/A 2031-08-24 | CTI BIOPHARMA CORP | CTIC | Parks Diane L. Director | 0 | $0 | 120,000 (Direct) | View |
| 2021-03-10 Option Award | 2021-03-12 9:04 pm | N/A 2031-03-10 | CTI BIOPHARMA CORP | CTIC | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N 10% Owner | 80,000 | $0 | 7,298,451 (Indirect) | View |
| 2021-03-10 Option Award | 2021-03-12 6:53 pm | N/A 2031-03-10 | CTI BIOPHARMA CORP | CTIC | Tuckson Reed Vaughn Director | 80,000 | $0 | 80,000 (Direct) | View |
| 2021-03-10 Option Award | 2021-03-12 6:51 pm | N/A 2031-03-10 | CTI BIOPHARMA CORP | CTIC | Metzger Michael A Director | 80,000 | $0 | 80,000 (Direct) | View |
| 2021-03-10 Option Award | 2021-03-12 6:50 pm | N/A 2031-03-10 | CTI BIOPHARMA CORP | CTIC | PERRY MATTHEW D Director | 80,000 | $0 | 80,000 (Direct) | View |
| 2021-03-10 Option Award | 2021-03-12 6:48 pm | N/A 2031-03-10 | CTI BIOPHARMA CORP | CTIC | Parkinson David Ross Director | 80,000 | $0 | 80,000 (Direct) | View |
| 2021-03-10 Option Award | 2021-03-12 6:46 pm | N/A 2031-03-10 | CTI BIOPHARMA CORP | CTIC | Fischer Laurent Director | 80,000 | $0 | 80,000 (Direct) | View |
| 2020-07-01 Option Award | 2021-03-12 6:45 pm | N/A 2031-03-10 | CTI BIOPHARMA CORP | CTIC | SEELEY BRUCE J. EVP Chief Operating Officer | 200,000 | $0 | 237,500 (Direct) | View |
| 2020-07-01 Option Award | 2021-03-12 6:45 pm | N/A N/A | CTI BIOPHARMA CORP | CTIC | SEELEY BRUCE J. EVP Chief Operating Officer | 5,000 | $0.98 | 237,500 (Direct) | View |
| 2020-07-01 Option Award | 2021-03-12 6:41 pm | N/A N/A | CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID CFO | 3,798 | $0.98 | 203,798 (Direct) | View |
| 2020-07-01 Option Award | 2021-03-12 6:38 pm | N/A 2031-03-10 | CTI BIOPHARMA CORP | CTIC | Craig Adam R CEO | 800,000 | $0 | 805,000 (Direct) | View |
| 2020-07-01 Option Award | 2021-03-12 6:38 pm | N/A N/A | CTI BIOPHARMA CORP | CTIC | Craig Adam R CEO | 5,000 | $0.98 | 805,000 (Direct) | View |
| 2020-06-30 Option Award | 2020-07-02 5:22 pm | N/A N/A | CTI BIOPHARMA CORP | CTIC | SEELEY BRUCE J. EVP Chief Operating Officer | 500 | $0.986 | 32,500 (Direct) | View |
| 2020-03-11 Option Award | 2020-03-13 7:58 pm | N/A 2030-03-11 | CTI BIOPHARMA CORP | CTIC | SEELEY BRUCE J. EVP Chief Operating Officer | 330,000 | $0 | 330,000 (Direct) | View |
| 2020-03-11 Option Award | 2020-03-13 7:51 pm | N/A 2030-03-11 | CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID CFO | 350,000 | $0 | 350,000 (Direct) | View |
| 2020-03-11 Option Award | 2020-03-13 7:46 pm | N/A 2030-03-11 | CTI BIOPHARMA CORP | CTIC | Tuckson Reed Vaughn Director | 126,000 | $0 | 126,000 (Direct) | View |
| 2020-03-11 Option Award | 2020-03-13 7:40 pm | N/A 2030-03-11 | CTI BIOPHARMA CORP | CTIC | Parkinson David Ross Director | 126,000 | $0 | 126,000 (Direct) | View |
| 2020-03-11 Option Award | 2020-03-13 7:35 pm | N/A 2030-03-11 | CTI BIOPHARMA CORP | CTIC | Fischer Laurent Director | 126,000 | $0 | 126,000 (Direct) | View |
| 2020-03-11 Option Award | 2020-03-13 7:30 pm | N/A 2030-03-11 | CTI BIOPHARMA CORP | CTIC | Craig Adam R CEO | 2,320,000 | $0 | 2,320,000 (Direct) | View |
| 2020-03-11 Option Award | 2020-03-13 6:31 pm | N/A 2030-03-11 | CTI BIOPHARMA CORP | CTIC | Metzger Michael A Director | 126,000 | $0 | 126,000 (Direct) | View |
| 2020-03-06 Ownership | 2020-03-10 5:05 pm | N/A N/A | CTI BIOPHARMA CORP | CTIC | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC 10% Owner | 0 | $0 | 12,500,000 (Indirect) | View |
| 2020-03-02 Exercise | 2020-03-04 9:12 pm | 2020-02-13 2020-03-02 | CTI BIOPHARMA CORP | CTIC | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N 10% Owner | 2,252 | $0 | 6,946,438 (Direct) | View |
| 2020-03-02 Ownership | 2020-03-04 9:08 pm | N/A N/A | CTI BIOPHARMA CORP | CTIC | BVF GP HOLDINGS LLC BVF I GP LLC BVF II GP LLC 10% Owner | 0 | $0 | 11,331,067 (Indirect) | View |
| 2019-05-16 Option Award | 2019-05-20 8:27 pm | N/A 2029-05-16 | CTI BIOPHARMA CORP | CTI | PERRY MATTHEW D See Explanation of Responses | 120,000 | $0 | 273,139 (Direct) | View |
| 2019-05-16 Option Award | 2019-05-20 6:46 pm | N/A 2029-05-16 | CTI BIOPHARMA CORP | CTIC | Fischer Laurent Director | 120,000 | $0 | 120,000 (Direct) | View |
| 2019-05-16 Option Award | 2019-05-20 6:11 pm | N/A 2029-05-16 | CTI BIOPHARMA CORP | CTIC | Metzger Michael A Director | 120,000 | $0 | 120,000 (Direct) | View |
| 2019-05-16 Option Award | 2019-05-20 5:26 pm | N/A 2029-05-16 | CTI BIOPHARMA CORP | CTIC | Tuckson Reed Vaughn Director | 120,000 | $0 | 120,000 (Direct) | View |
| 2019-05-16 Option Award | 2019-05-20 4:58 pm | N/A 2029-05-16 | CTI BIOPHARMA CORP | CTIC | Parkinson David Ross Director | 120,000 | $0 | 120,000 (Direct) | View |